A Rash Around the Mouth and Chin in Sydney: Why Perioral Dermatitis Needs a Different Approach

A cluster of small bumps around the mouth, on the chin or beside the nostrils is easy to mistake for a breakout. The instinctive response is often to treat it like acne: a stronger active, a more thorough cleanse, or whatever anti-inflammatory cream is already in the bathroom cupboard.

For some people that approach helps. For others the rash persists for months, settles briefly, then returns. One reason is that not every acne-like eruption around the mouth is acne. Perioral dermatitis — known more broadly as periorificial dermatitis when it also involves the eye or nose areas — behaves differently, and some of the things that help other facial rashes can prolong it.

This is general education for adults reviewing a persistent lower-face rash before a consultation. It is not a diagnosis, and it does not replace assessment by a doctor.

What Perioral Dermatitis Is

DermNet describes periorificial dermatitis as a relatively common chronic inflammatory eruption that preferentially affects the skin around facial openings: the mouth, the nostrils, the eyes and occasionally other sites. When it is limited to the area around the mouth, it is called perioral dermatitis.

The described features include:

• Clusters of skin-coloured to red papules, and sometimes small vesicles or pustules
• Individual bumps usually smaller than about 2 mm, which may merge into larger patches
• A background of redness with a relatively sharp border
• Dry, scaly or flaky-looking surrounding skin
• Burning, tightness or itch rather than pain

One detail is frequently noticed by clients themselves: the narrow strip of skin immediately bordering the lips is often spared, with the rash starting a few millimetres out. DermNet notes this sparing as characteristic, though it is not universal and is not something to self-assess as proof of anything.

DermNet reports that it is seen more often in women roughly between 20 and 45 years of age, and also occurs in children. Those are population observations, not a rule about who can develop it.

Why It Is Not Simply Treated Like Acne

Acne and perioral dermatitis can look similar at a glance, but DermNet lists distinguishing considerations: acne typically involves comedones — blackheads and whiteheads — along with nodules or cysts, which are not typical of perioral dermatitis. Rosacea and seborrhoeic dermatitis are also on the differential list, each with a different distribution and different associated features.

That distinction matters because it changes what a clinician is likely to recommend. Aggressive scrubbing, layering multiple actives, or occluding the area heavily are unlikely to resolve an inflammatory eruption of this type, and may add irritation to skin that is already sensitive.

There is no reliable way to separate these conditions from a photo, a symptom checklist or an online comparison. More than one condition can also be present on the same face at the same time.

The Topical Steroid Issue

This is the point that most changes client behaviour, and it deserves careful wording.

Topical corticosteroids are legitimate, effective medicines with real and appropriate uses, including on facial skin when a doctor prescribes them for the right condition at the right potency. Australian Prescriber notes that corticosteroid avoidance driven by fear is itself a common cause of treatment failure in conditions such as atopic dermatitis, and that appropriate use is safe and effective.

At the same time, Australian sources consistently list periorificial and perioral dermatitis among the recognised adverse effects associated with topical corticosteroid use on the face. Australian Prescriber advises that only the weakest topical corticosteroids are relatively safe for facial skin and eyelids, and that higher-potency products applied to the face commonly cause periorificial dermatitis, a form of steroid-induced rosacea. Its dermatology guidance also lists perioral and periocular dermatitis among adverse effects related to topical corticosteroids, and recommends avoiding prolonged use on the face where possible.

DermNet identifies steroid exposure by any route — topical, inhaled or nasal — as the most common association with periorificial dermatitis, and notes that exposure can be unintentional, such as from a nasal spray. It also describes a rebound flare that may follow abruptly stopping a potent facial topical steroid.

Two practical implications follow, and both point toward a doctor rather than a shortcut:

1. Do not borrow or repurpose a steroid cream for a facial rash. A product prescribed for another body area, another condition or another person may be the wrong potency for facial skin.
2. Do not abruptly stop a prescribed steroid on your own. DermNet describes weaning under medical guidance, precisely because sudden cessation can be followed by a flare. Medically necessary nasal, inhaled or oral steroids should be continued and discussed with the prescribing doctor, not silently dropped.

Prescription-only medicines, including topical corticosteroids and the antibiotics sometimes used for this condition, require individual medical assessment. Nothing in this article should be used to start, stop or change a prescribed medicine.

Other Reported Associations

DermNet lists several factors associated with periorificial dermatitis, while stating plainly that the exact cause is not understood. Reported associations include cosmetic use, heavily occlusive emollients such as paraffin or petroleum-based products, certain sunscreens, contact reactions to toothpaste and other oral hygiene products, hormonal factors, and an atopic predisposition. Physical factors such as UV light, heat and wind are described as worsening it.

For Sydney clients heading into spring, that last group is worth noting simply as context. Warmer, brighter, windier days often coincide with more time outdoors and changes in sunscreen and makeup routines. An association is not proof of cause in any individual case, and identifying a trigger is part of a clinical conversation rather than a self-experiment.

What a Gentle Holding Pattern Looks Like

While waiting for assessment, the reasonable goal is to avoid adding irritation — not to treat the rash.

DermNet describes a general "zero-therapy" approach used in this condition, which involves simplifying facial topical products under clinical guidance. In practice, before a consultation, that usually means:

1. Wash gently, with lukewarm water or a non-soap cleanser, without scrubbing the affected skin.
2. Pause non-essential facial products — new actives, exfoliants, heavy occlusive balms and fragranced items — rather than adding more.
3. If dryness is uncomfortable, use a bland, simple moisturiser sparingly; DermNet notes that heavily occlusive creams and ointments can worsen this condition.
4. Keep sun protection appropriate for Sydney conditions, and discuss which formulation suits your skin at your appointment.
5. Write down when the rash started, what products or sprays were used beforehand, and what has changed since.

This is a holding pattern to reduce irritation while you get advice. It is not a treatment, and it will not resolve an established inflammatory rash.

When to Seek Medical Review

Book a review with a doctor rather than continuing to trial products if:

• A rash around the mouth, nose or eyes persists for more than a couple of weeks
• The rash keeps returning after seeming to settle
• It appeared or worsened after using a steroid cream, nasal spray or inhaler
• It is spreading, weeping, crusted or becoming painful
• The eye area is involved
• The rash is affecting a child
• You are pregnant, breastfeeding or taking other medicines, since this affects treatment options
• It is causing you significant distress

Seek prompt medical care if you develop fever, rapidly spreading redness, swelling or other signs of infection, or any symptom that worries you. In Australia, healthdirect can be reached on 1800 022 222, and in an emergency call triple zero (000).

How a Skin Clinic Fits In

A cosmetic skin clinic is not the place to diagnose or prescribe for an inflammatory facial rash. Diagnosis of periorificial dermatitis is clinical, and DermNet notes that investigations such as swabs, patch testing or biopsy may be used where there is uncertainty. That is a medical assessment, typically starting with a GP and sometimes involving a dermatologist.

What a clinic can appropriately do is recognise when a presentation is outside cosmetic scope and say so. At SkinSpirit, a consultation is a conversation about your skin, your history and what is suitable — including when the right recommendation is to see a doctor first, and when cosmetic treatments should be paused until active inflammation has settled.

Outcomes vary between individuals. DermNet notes that periorificial dermatitis is generally benign and self-limiting but may run a chronic course lasting months to years without treatment, that most people respond well to treatment, and that recurrence can occur. No article, clinic or product can promise a particular result for your skin.

In Short

A persistent rash around the mouth and chin is worth identifying rather than treating by guesswork. Perioral dermatitis is a recognised condition with its own pattern, its own well-documented association with facial steroid use, and its own medical management. Simplify what you are applying, avoid improvising with prescription products, record what you have noticed, and get it assessed.

---

The photograph accompanying this article is a general image of the lower face and perioral area used to illustrate the region discussed. It does not depict a patient, a diagnosis, a treatment or a result.

This article is general information only and is not medical advice, a diagnosis or a treatment recommendation. Individual circumstances differ. Please consult your GP, a dermatologist or another qualified health practitioner about your own skin, and about any prescription medicine. Sources consulted: DermNet (periorificial dermatitis), Australian Prescriber (treatments for atopic dermatitis; the role of corticosteroids in dermatology) and RACGP guidance on topical corticosteroid selection.